Bulletin
Investor Alert

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 25, 2020, 7:58 p.m.

/zigman2/quotes/209129655/composite

$

4.78

Change

-0.01 -0.21%

Volume

Volume 27,309

Quotes are delayed by 20 min

/zigman2/quotes/209129655/composite

Previous close

$ 4.75

$ 4.79

Change

+0.04 +0.84%

Day low

Day high

$4.64

$4.89

Open

52 week low

52 week high

$2.43

$27.21

Open

Insider Actions for Tilray Inc. Cl 2

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/22/2020 Brendan Kennedy
President and CEO; Director
500,000   Disposition at $5.13 per share. 2,565,000
09/22/2020 Brendan Kennedy
President and CEO; Director
500,000   Derivative/Non-derivative trans. at $0 per share. 0
09/21/2020 Brendan Kennedy
President and CEO; Director
500,000   Disposition at $5.01 per share. 2,505,000
09/21/2020 Brendan Kennedy
President and CEO; Director
117,244   Derivative/Non-derivative trans. at $0 per share. 0
09/18/2020 Andrew Pucher
Chief Corporate Dev Officer
7,497   Derivative/Non-derivative trans. at $0 per share. 0
09/01/2020 Rebekah Dopp
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
09/01/2020 Christine Thompson St. Clare
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
09/01/2020 Maryscott Greenwood
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
09/01/2020 Maryscott Greenwood
Director
5,000   Disposition at $6.44 per share. 32,200
08/03/2020 Michael Shtender-Auerbach
Director
75,526   Disposition at $7.27 per share. 549,074
08/03/2020 Michael Shtender-Auerbach
Director
279,608   Disposition at $7.28 per share. 2,035,546
08/03/2020 Maryscott Greenwood
Director
5,000   Disposition at $7.27 per share. 36,350
08/03/2020 Michael Shtender-Auerbach
Director
5,717   Derivative/Non-derivative trans. at $2.51 per share. 14,349
08/03/2020 Michael Shtender-Auerbach
Director
21,458   Derivative/Non-derivative trans. at $2.51 per share. 53,859
08/03/2020 Michael Shtender-Auerbach
Director
21,458   Derivative/Non-derivative trans. at $1.25 per share. 26,822
08/03/2020 Michael Shtender-Auerbach
Director
107,290   Derivative/Non-derivative trans. at $1.25 per share. 134,112
08/03/2020 Michael Shtender-Auerbach
Director
3,168   Derivative/Non-derivative trans. at $0.19 per share. 601
07/16/2020 Brendan Kennedy
President and CEO; Director
116,668   Disposition at $7.69 per share. 897,176
07/15/2020 Brendan Kennedy
President and CEO; Director
116,666   Disposition at $7.76 per share. 905,328
07/14/2020 Brendan Kennedy
President and CEO; Director
116,666   Disposition at $7.42 per share. 865,661
07/05/2020 Edward Wood Pastorius
Chief Revenue Officer
7,822   Derivative/Non-derivative trans. at $3.13 per share. 24,482
07/05/2020 Edward Wood Pastorius
Chief Revenue Officer
4,693   Derivative/Non-derivative trans. at $5.28 per share. 24,779
07/01/2020 Brendan Kennedy
President and CEO; Director
18,446   Derivative/Non-derivative trans. at $7.01 per share. 129,306
07/01/2020 Edward Wood Pastorius
Chief Revenue Officer
1,812   Derivative/Non-derivative trans. at $7.01 per share. 12,702
07/01/2020 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2020 Michael Shtender-Auerbach
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2020 Edward Wood Pastorius
Chief Revenue Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
14 Purchases
13 Sales
240,976
2,352,636
Last 6 months
31 Purchases
24 Sales
540,940
4,164,811
Last 12 months
52 Purchases
37 Sales
4,406,762
4,558,439

Officers and Executives

Mr. Brendan Kennedy
President, Chief Executive Officer & Director
Mr. Jon Levin
Chief Operating Officer
Mr. Michael Kruteck
Chief Financial Officer
Dr. Joshua Eades
Chief Science Officer & Vice President
Mr. Mark Castaneda
Head-Strategic Business Development
Mr. Andrew Pucher
Chief Corporate Development Officer
Mr. Edward Wood Pastorius
Chief Revenue Officer
Ms. Adine Fabiani-Carter
Chief Marketing Officer
Ms. Rita Seguin
Executive Vice President-Human Resources
Ms. Dara Redler
Secretary & General Counsel
Ms. Catherine Jacobson
VP-Regulatory & Medical Affairs
Mr. Soren W. Schroder
Independent Director
Ms. Christine Thompson St. Clare
Independent Director
Ms. Maryscott Greenwood
Independent Director
Ms. Rebekah Dopp
Independent Director
Mr. Michael Shtender-Auerbach
Independent Director
Link to MarketWatch's Slice.